Case Study

MVP: MediMergent’s My Vaccine Program

MVP addresses issues of vaccine hesitancy and resistance and aids in the fight to control COVID-19

The MVP is a patient engagement platform that educates, communicates and monitors the health status of consumers including attitudes, behaviors and outcomes related to COVID-19. The platform informs consumers on issues related to the virus, exposure, prevention, testing, infection, treatment, vaccination, and follow-up. It also collects serial data over 3 months related to consumers’ vaccine experience including medical history related to chronic diseases, medications, potential side effects or adverse events, medical intervention and outcomes.

Powered by MediMergent, the platform collects Real-World Evidence (RWE) related to post-COVID vaccination safety surveillance and multiple covariates including age, sex, race, ethnicity, community/zip code, and other social determinants of health (SDOH). Deploying a suite of digital apps, the MVP collects data on the COVID-19 vaccine linked to preventive care and disease management i.e., real-time monitoring of people with chronic diseases and methods to mitigate risks related to exposure, infection, hospitalization and potential death from the coronavirus. Proprietary analytics are applied to produce a comprehensive, multi-variate description of the population health and the effectiveness of its strategies to contain and eradicate COVID-19. The app-based platform collects Real-World Data (RWD) that is adjunctive to the serial data collected by the CDC via the V-Safe platform.

For More Information About the MVP Please Contact MediMergent